ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Minnesota » Rheumatology

Top Rheumatology Prescribers in Minnesota

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ASIM KHAN MD

Rheumatology

6,107

$693K

767
560 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

1%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$114
Average prescription price

Avg: $173

JURGEN CRAIG-MUELLER MD

Rheumatology

4,290

$516K

509
418 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

3%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$120
Average prescription price

Avg: $173

MARTHA GRANDITS MD

Rheumatology

4,089

$732K

396
256 are 65+

13%
patients receiving schedule two controlled substances

Avg: 2%

16%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$179
Average prescription price

Avg: $173

PAUL WAYTZ M.D.

Rheumatology

4,003

$334K

467
401 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

3%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$83
Average prescription price

Avg: $173

ARCHIBALD SKEMP M.D.

Rheumatology

3,762

$506K

464
382 are 65+

2%
patients receiving schedule two controlled substances

Avg: 2%

9%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 24%

$134
Average prescription price

Avg: $173

KURT ZIMMERMAN M.D.

Rheumatology

3,443

$720K

401
335 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

10%
patients receiving schedule three controlled substances

Avg: 5%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 24%

$209
Average prescription price

Avg: $173

GARY BAKER MD

Rheumatology

3,425

$649K

471
351 are 65+

2%
patients receiving schedule two controlled substances

Avg: 2%

3%
patients receiving schedule three controlled substances

Avg: 5%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 24%

$190
Average prescription price

Avg: $173

WALTER DORMAN M.D.

Rheumatology

3,416

$380K

346
298 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

4%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$111
Average prescription price

Avg: $173

MAYRA OBERTO-MEDINA DO

Rheumatology

3,219

$372K

526
363 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

3%
patients receiving schedule three controlled substances

Avg: 5%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$116
Average prescription price

Avg: $173

ROBERT LEFF

Rheumatology

3,127

$1.18M

453
285 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

11%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 24%

$378
Average prescription price

Avg: $173

PETER SCHLESINGER MD

Rheumatology

3,066

$397K

194
87 are 65+

25%
patients receiving schedule two controlled substances

Avg: 2%

16%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$130
Average prescription price

Avg: $173

VERNON BERGLUND M.D.

Rheumatology

3,004

$460K

334
279 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

7%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$153
Average prescription price

Avg: $173

DONNA FONTANA M.D., PH. D.

Rheumatology

2,910

$295K

296
245 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 24%

$102
Average prescription price

Avg: $173

MICHAEL EDWARDS MD

Rheumatology

2,808

$1.67M

317
144 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

8%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 24%

$594
Average prescription price

Avg: $173

JYOTHSNA RAYADURG MD

Rheumatology

2,808

$173K

290
232 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$61
Average prescription price

Avg: $173

PETER KENT M.D.

Rheumatology

2,798

$410K

420
336 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

20%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$146
Average prescription price

Avg: $173

ERSKINE CAPERTON M.D.

Rheumatology

2,767

$763K

256
215 are 65+

8%
patients receiving schedule two controlled substances

Avg: 2%

12%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$276
Average prescription price

Avg: $173

ROBERT TIERNEY M.D.

Rheumatology

2,751

$858K

435
343 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

3%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 24%

$312
Average prescription price

Avg: $173

ANA FERNANDEZ-POKORNY

Rheumatology

2,619

$484K

422
281 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

6%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$185
Average prescription price

Avg: $173

SUSAN LEONARD MD

Rheumatology

2,593

$400K

381
313 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 24%

$154
Average prescription price

Avg: $173

ALI SAJJAD MD

Rheumatology

2,553

$234K

322
270 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$92
Average prescription price

Avg: $173

THOMAS HARKCOM MD

Rheumatology

2,292

$543K

446
343 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

3%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 24%

$237
Average prescription price

Avg: $173

HAMMAD BAJWA M.D.

Rheumatology

2,285

$294K

311
243 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$129
Average prescription price

Avg: $173

SALMAN WAHEEDUDDIN MBBS

Rheumatology

2,251

$240K

291
233 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$107
Average prescription price

Avg: $173

AARON HOLMGREN MD

Rheumatology

2,218

$232K

267
207 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

8%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$105
Average prescription price

Avg: $173

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank